Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Vaxcyte (PCVX) Equity Ratio (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Equity Ratio data on record, last reported at 0.89 in Q1 2026.

  • On a quarterly basis, Equity Ratio fell 5.54% to 0.89 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.89, a 5.54% decrease, with the full-year FY2025 number at 0.89, down 5.0% from a year prior.
  • Equity Ratio reached 0.89 in Q1 2026 per PCVX's latest filing, roughly flat from 0.89 in the prior quarter.
  • Over the last five years, Equity Ratio for PCVX hit a ceiling of 0.96 in Q3 2024 and a floor of 0.87 in Q3 2022.
  • A 5-year average of 0.92 and a median of 0.94 in 2023 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: rose 8.23% in 2022, then fell 7.04% in 2023.
  • Tracing PCVX's Equity Ratio over 5 years: stood at 0.95 in 2022, then dropped by 7.04% to 0.88 in 2023, then grew by 6.86% to 0.94 in 2024, then fell by 5.0% to 0.89 in 2025, then increased by 0.05% to 0.89 in 2026.
  • Business Quant data shows Equity Ratio for PCVX at 0.89 in Q1 2026, 0.89 in Q4 2025, and 0.91 in Q3 2025.